Cystic Fibrosis

Top Story

Keeping a safe distance: That's 6 feet for patients with cystic fibrosis

Keeping a safe distance: That's 6 feet for patients with cystic fibrosis
January 16, 2019

Pliant Therapeutics raises $62 million for proof-of-concept fibrosis studies

July 16, 2018
Pliant Therapeutics raised $62 million in a series B financing to support proof-of-concept clinical trials in idiopathic pulmonary fibrosis, primary sclerosing…

Anthera halts development of EPI drug candidate Sollpura

March 13, 2018
Anthera Pharmaceuticals announced it will discontinue the development of Sollpura after the drug failed to meet the primary endpoint of a phase 3 trial. Sollpura…
In the Journals Plus

Oral therapy as safe, effective as insulin in cystic fibrosis-related diabetes

December 7, 2017
Patients with cystic fibrosis-related diabetes treated with oral repaglinide for 24 months experienced improvements in HbA1c and pulmonary function that were similar to…
More Headlines »
Special Issue Article

Cystic Fibrosis–Related Diabetes in Children: An Update

Pediatric Annals, September 2016, Volume 45 Issue 9
Cystic fibrosis–related diabetes mellitus (CFRD) is the most common endocrine complication of cystic fibrosis (CF)…
More »
Video
Meeting News

VIDEO: Pembrolizumab improves overall survival in nonsmall cell lung cancer

May 5, 2017
More »
Healio Jobs